<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/NewsArticle>
<http://www.fiercebiotech.com/press-releases/aeterna-zentaris-granted-special-protocol-assessment-fda-phase-3-registrati>